Cargando…
Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
OBJECTIVE: To conduct a validation study of (123)I-N-fluoropropyl-2b-carbomethoxy-3b-(4-iodophenyl) nortropane ((123)I-FP-CIT) SPECT dopaminergic imaging in the clinical diagnosis of dementia with Lewy bodies (DLB) with autopsy as the gold standard. METHODS: Patients >60 years of age with dementi...
Autores principales: | Thomas, Alan J., Attems, Johannes, Colloby, Sean J., O'Brien, John T., McKeith, Ian, Walker, Rodney, Lee, Lean, Burn, David, Lett, Debra J., Walker, Zuzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272795/ https://www.ncbi.nlm.nih.gov/pubmed/27940650 http://dx.doi.org/10.1212/WNL.0000000000003512 |
Ejemplares similares
-
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
por: Walker, Zuzana, et al.
Publicado: (2016) -
Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018) -
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
por: De Feo, Maria Silvia, et al.
Publicado: (2023) -
Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration
por: Akahoshi, Miho, et al.
Publicado: (2017) -
Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)